布地奈德雾化吸入治疗急性会厌炎的疗效观察  

作　　者：周宇亮[1] 

机构地区：[1]苏州市立医院东区,215001

出　　处：《内蒙古中医药》2012年第24期89-90,共2页Inner Mongolia Journal of Traditional Chinese Medicine

摘　　要：目的:研究分析布地奈德治疗急性会厌炎的疗效。方法:选择82例急性会厌炎患者,随机分成两组,分别给予雾化吸入布地奈德和地塞米松,其他治疗基本相同,统计分析治疗效果。结果:布地奈德组有效率为97.7%(43/44),显效率为93.2%(41/44);地塞米松组有效率为78.9%(30/38),显效率为73.7%(28/38);两组间有效率及显效率差异具有显著性意义(P<0.05)。结论:雾化吸入布地奈德治疗急性会厌炎起效快,局部抗炎作用强,时间长,能快速减轻会厌水肿,缓解症状,降低气管切开率。Objective：To study the efficacy of budesonide in the treatment of acute epiglottitis. Methods：82 patients with acute epiglottitis, were randomly divided into two groups, were given nebulized budesonide and dexamethasone, other treatment is basically the same, statistical anal- ysis of therapeutic effect. The results of the budesonide group businesslike for 97.7% （ 43 / 44）, markedly effective rate was 93.2% （ 41 / 44）; dexamethasone group businesslike for 78.9% （ 30 / 38）, markedly effective rate was 73.7% （ 28 / 38）; between the two groups have efficiency and significant efficiency had significant difference （ P〈0.05 ）. Conclusion：nebulized budesonide in the treatment of acute epiglottitis in rapid onset, topical anti-inflammatory action is strong, a long time, can quickly reduce the epiglottic edema, relieve symptoms, reduce the rate of incision of trachea.

关 键 词：会厌炎 布地奈德 喉阻塞 气管切开术 

分 类 号：R725.6[医药卫生—儿科]